EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

A Double Blind Randomised Controlled Trial Comparing Glenohumeral Cortisone With and Without Hydrodilatation in Patients With Frozen Shoulder

Alastair Konarski iD, Kishen Narayanasamy, Jennifer Coghlan, Timothy Chung, Matthew Andrews, Simon Bell

ANZ Journal of Surgery · 2025

DOI: 10.1111/ans.70200 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Alastair Konarski und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Melbourne Shoulder and Elbow Centre, Melbourne, Australia. Hauptthemen laut MEDLINE: Bursitis, Cortisone, Glucocorticoids, Shoulder Joint. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frozen shoulder (FS) is a common condition causing pain and stiffness in the shoulder. There is controversy over whether hydrodilatation (HD) gives improved outcomes compared to corticosteroid injection (CSI) alone. The aim of this study was to investigate if HD improves outcomes compared to CSI alone.

Methods

This was a double‐blinded RCT. Patients aged 18–90 with FS were included. The CSI group received an injection of contrast followed by local anaesthetic and steroid. The HD group received the same, followed by saline until capsular rupture or severe resistance. The primary outcome was pain‐free range of motion (ROM), along with Shoulder Pain and Disability Index (SPADI) 8 weeks post‐intervention, and American Shoulder and Elbow Surgeons Score (ASES), Simple Shoulder Test (SST) and Constant score.

Results

Seventy‐nine patients were included, with a mean age of 54 (29–70), 53% female. The ROM and SPADI improved in both groups (CSI from 57.4 to 35.8, HD from 57.7 to 32.7) along with ASES, SST and Constant. There were no significant differences between the groups at 8 weeks. HD was found to be more painful than CSI. Male patients achieved greater improvement in ER with HD, while females, patients with severe pain at presentation, and symptoms for less than 120 days favoured CSI.

Conclusion

Both groups significantly improved, but there were no significant differences between the groups, although there were some differences between subgroups. We recommend tailoring the first‐line treatment according to patient symptoms and baseline characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BursitisCortisoneGlucocorticoidsShoulder JointAdultAgedFemaleHumansMaleMiddle AgedDouble-Blind MethodInjections, Intra-ArticularPain MeasurementRange of Motion, ArticularTreatment Outcome

Stichwörter der Autor:innen

adhesive capsulitiscorticosteroidfrozen shoulderhydrodilatationinjection

Substanzen

CortisoneGlucocorticoids

Autor:innen und Institutionen

  • The Melbourne Shoulder and Elbow Centre, Melbourne, Australia.
  • Department of Surgery, School of Clinical Sciences, Monash University, Melbourne, Australia.
  • I-MED Radiology, Cabrini Hospital, Melbourne, Australia.

ORCID-Profile: Alastair Konarski

Zitieren

APA

Konarski, A., Narayanasamy, K., Coghlan, J., Chung, T., Andrews, M., & Bell, S. (2025). A Double Blind Randomised Controlled Trial Comparing Glenohumeral Cortisone With and Without Hydrodilatation in Patients With Frozen Shoulder. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70200

Vancouver

Konarski A, Narayanasamy K, Coghlan J, Chung T, Andrews M, Bell S. A Double Blind Randomised Controlled Trial Comparing Glenohumeral Cortisone With and Without Hydrodilatation in Patients With Frozen Shoulder. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70200

BibTeX
@article{Konarski2025,
  author = {Konarski, Alastair and Narayanasamy, Kishen and Coghlan, Jennifer and Chung, Timothy and Andrews, Matthew and Bell, Simon},
  title = {A Double Blind Randomised Controlled Trial Comparing Glenohumeral Cortisone With and Without Hydrodilatation in Patients With Frozen Shoulder},
  journal = {ANZ Journal of Surgery},
  year = {2025},
  doi = {10.1111/ans.70200}
}
Kostenlos starten →